The FDA has the authority to enforce mandatory recalls for medical devices and recommend recalls for prescription and over-the-counter drugs, but cannot enforce drug recalls.
The $3.2 billion budget is $40.8 million more than the FDA’s 2020 budget.
It is unclear whether the Senate will finalize the budget before the beginning of the next fiscal year on Oct. 20, Endpoints News reported. The Senate must approve it before the FDA gets the authority to enforce drug recalls.
Find the House’s summary of the budget here.
More articles on pharmacy:
Walgreens CEO steps down
AstraZeneca, Daiichi Sankyo partner in $6B cancer drug deal
Trump signs 4 executive orders targeting drug prices: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
